Physician profile
Steven B Cancell
NPI 1003875915
$3,674.02
in general payments reported to CMS, 2019-2025
16 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,625 · 2020: $1,418 · 2021: $106 · 2022: $119 · 2023: $187 · 2024: $73.80 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $2,737.63 | 2019-2020 | |
| Stryker Corporation | $283.68 | 2019-2025 | Sonicpin, Dart-Fire, Ortholoc 2 Lapifuse |
| Wright Medical Technology, INC. | $193.25 | 2019-2020 | |
| Smith+Nephew, INC. | $103.67 | 2019-2025 | Collagenase Santyl, Stravix |
| Bioventus LLC | $70.08 | 2020-2021 | |
| Eclipse Technology Solutions INC. | $61.68 | 2022-2025 | |
| Integra Lifesciences Corporation | $46.45 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $30.73 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Acera Surgical, INC. | $24.94 | 2025 | Restrata Wound Matrix |
| Organogenesis INC. | $23.73 | 2023 | Puraply |
| Abbvie INC. | $19.94 | 2022 | |
| Nuvasive, INC. | $19.49 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.98 | 2025 | Nuzyra |
| Zimmer Biomet Holdings, INC. | $15.20 | 2022 | |
| Lifenet Health | $14.50 | 2025 | Theragenesis Wound Matrix |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $13.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Cancell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.